Viewing data from:

DICLOFENAC POTASSIUM

ANDA

DICLOFENAC POTASSIUM | A215750 | UMEDICA LABORATORIES PRIVATE LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$5.22

per ea

Lowest NADAC/Unit

$0.0998

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
75834033730DICLOFENAC POT 25 MG TABLET	$5.22	EA	Generic	—	2026-06-17
75834033760DICLOFENAC POT 25 MG TABLET	$5.22	EA	Generic	—	2026-06-17
70710183201DICLOFENAC POT 50 MG TABLET	$0.0998	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs4 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

YUNG ZIP CHEMICAL IND CO LTDDICLOFENAC POTASSIUM

DMF 108311994

OLON SPADICLOFENAC POTASSIUM

DMF 112671994

SYN-TECH CHEM AND PHARM CO LTDDICLOFENAC POTASSIUM USP

DMF 126561997

DIPHARMA FRANCIS SRLDICLOFENAC POTASSIUM

DMF 130451998

UNIQUE CHEMICALSDICLOFENAC POTASSIUM USP

DMF 150742000

AMOLI ORGANICS PRIVATE LTDDICLOFENAC POTASSIUM USP

DMF 230282009

HENAN DONGTAI PHARM CO LTDDICLOFENAC POTASSIUM

DMF 305152016

CHENG FONG CHEMICAL CO LTDInactiveDICLOFENAC POTASSIUM

DMF 119901996

ESTEVE QUIMICA SAInactiveDICLOFENAC POTASSIUM

DMF 120211996

FARCHEMIA SRLInactiveDICLOFENAC POTASSIUM

DMF 122171996

CAMBREX PROFARMACO CORK LTDInactiveDICLOFENAC POTASSIUM

DMF 139341999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 11, 2022

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 30, 2025